Richard Jacroux
Chief Financial Officer · ENDRA Life Sciences Inc.
Individual
- 2026
- Mar 5, 2026
- 2
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Richard Jacroux's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- BAKER BROS. ADVISORS LP - $172.50M in KYMR purchases and sales in the last 12 months
- Keith S. Manchester - $154.47M in ROIV purchases and sales in the last 12 months
- QVT Financial LP - $147.38M in ROIV purchases and sales in the last 12 months
- Daniel Allen Gold - $147.38M in ROIV purchases and sales in the last 12 months
- ULSE Inc. - $146.25M in ULS purchases and sales in the last 12 months
- Michael Benkowitz - $135.23M in UTHR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Richard Jacroux?
Richard Jacroux is a corporate insider, tracked as Chief Financial Officer of ENDRA Life Sciences Inc. (NDRA). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Richard Jacroux last file a Form 4?
The most recent primary Form 4 on record is dated 5 March 2026, one of 2 filings going back to 2026.
